| James G Lahti, MD | |
|
400 Skokie Blvd, Suite 475, Northbrook, IL 60062-7930 | |
| (847) 272-4433 | |
| Not Available |
| Full Name | James G Lahti |
|---|---|
| Gender | Male |
| Speciality | Dermatology |
| Experience | 30 Years |
| Location | 400 Skokie Blvd, Northbrook, Illinois |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1689783086 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207N00000X | Dermatology | (Illinois) | Primary |
| 207ND0101X | Dermatology - Mohs-micrographic Surgery | (Illinois) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Northshore University Healthsystem - Evanston Hospital | Evanston, IL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Dermatology Partners Of The North Shore Llc | 2264427251 | 11 |
News Archive
Alkermes plc today announced the initiation of the pivotal clinical development program for ALKS 5461, a once-daily, oral investigational medicine with a novel mechanism of action for the adjunctive treatment of major depressive disorder (MDD).
In newly released research, 79 migraine sufferers were followed for at least five years after having undergone detection of migraine "trigger sites" and surgery. The new data finds promising outcomes for treating trigger sites surgically for migraine headaches resulting in elimination of pain for those afflicted with the condition.
A new study presents data on long covid in adults and children, which is becoming a major issue in public health planning.
Researchers have developed a technique for coating polymer implants with a bioactive film that significantly increases bonding between the implant and surrounding bone in an animal model.
› Verified 7 days ago
| Entity Name | Dermatology Partners Of The North Shore Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1114063591 PECOS PAC ID: 2264427251 Enrollment ID: O20040419000918 |
News Archive
Alkermes plc today announced the initiation of the pivotal clinical development program for ALKS 5461, a once-daily, oral investigational medicine with a novel mechanism of action for the adjunctive treatment of major depressive disorder (MDD).
In newly released research, 79 migraine sufferers were followed for at least five years after having undergone detection of migraine "trigger sites" and surgery. The new data finds promising outcomes for treating trigger sites surgically for migraine headaches resulting in elimination of pain for those afflicted with the condition.
A new study presents data on long covid in adults and children, which is becoming a major issue in public health planning.
Researchers have developed a technique for coating polymer implants with a bioactive film that significantly increases bonding between the implant and surrounding bone in an animal model.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| James G Lahti, MD 400 Skokie Blvd, Suite 475, Northbrook, IL 60062-7930 Ph: (847) 272-4433 | James G Lahti, MD 400 Skokie Blvd, Suite 475, Northbrook, IL 60062-7930 Ph: (847) 272-4433 |
News Archive
Alkermes plc today announced the initiation of the pivotal clinical development program for ALKS 5461, a once-daily, oral investigational medicine with a novel mechanism of action for the adjunctive treatment of major depressive disorder (MDD).
In newly released research, 79 migraine sufferers were followed for at least five years after having undergone detection of migraine "trigger sites" and surgery. The new data finds promising outcomes for treating trigger sites surgically for migraine headaches resulting in elimination of pain for those afflicted with the condition.
A new study presents data on long covid in adults and children, which is becoming a major issue in public health planning.
Researchers have developed a technique for coating polymer implants with a bioactive film that significantly increases bonding between the implant and surrounding bone in an animal model.
› Verified 7 days ago
Peter S Hallarman, M.D. Dermatology Medicare: Medicare Enrolled Practice Location: 400 Skokie Blvd, Suite 475, Northbrook, IL 60062 Phone: 847-272-4433 | |
Dr. Julie S Goldberg, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 513 Waukegan Rd, Northbrook, IL 60062 Phone: 847-205-0007 Fax: 847-205-0099 | |
Dr. Kelly Park, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1200 Shermer Rd Ste 200, Northbrook, IL 60062 Phone: 847-559-0090 | |
Gina C Marafino, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 400 Skokie Blvd, Suite 475, Northbrook, IL 60062 Phone: 847-272-4433 | |
Renata M Jenkin, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 400 Skokie Blvd Ste 475, Northbrook, IL 60062 Phone: 847-272-4433 Fax: 847-272-4434 | |
Anne K Bronner, M.D. Dermatology Medicare: Not Enrolled in Medicare Practice Location: 400 Skokie Blvd, Suite 475, Northbrook, IL 60062 Phone: 847-272-4433 |